June 2026 • PharmaTimes Magazine • 3
Nothing to Keir (except Keir itself)
As a writer and as someone who is duty bound to occasionally make precise reference to the bill payer at 10 Downing Street, the use of square brackets, with a last-moment instruction to drop in the ‘correct’ leader of this country is become absurdly common.
Even when that name is duly inserted, there is no guarantee that the name will be correct when the reader’s eyes and brain process his or her credentials.
For years square brackets have existed in the shadows and, yet, through an embarrassing set of democratic and, indeed, non-democratic circumstances they have become the de facto kings of punctuation, even if they never see the light of day.
As editors, we drag square brackets from the suite of lesser-spotted keyboard characters with discombobulating regularity.
And it’s not a task any of us relish. [Liz Truss] is not an insertion I would wish on my worst enemy. No, not even [Nigel Farage]. The truth is that all this dirt-digging and tittle-tattle, and the installation of a revolving door at the Prime Minister’s residence has consequences for pharma.
10 Downing Streeting is by no means a guarantee. The position he vacated in order to chase the poisoned chalice caused unwanted turbulence throughout the healthcare system. [Insert something here about waiting times, dentistry and surgery being forgotten in the whirlwind of posturing and chaos.]
Enjoy the mag,
editor
PharmaTimes Media Ltd,
44 Maiden Lane
Covent Garden
London
WC2E 7LN
Tel: +44 (0)20 7240 6999
pharmatimes.com
Twitter: @PharmaTimes
MAGAZINE
John Pinching / editor
john.pinching@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
COMPETITIONS
Luci Sargood / business manager
luci.sargood@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
James Tansill / Marketing Executive
james.tansill@pharmatimes.com
PMGROUP
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com
Iona Everson / group managing editor
iona.everson@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com
SUBSCRIPTIONS/REPRINTS
Digital and paper copies available
free to qualifying readers:
www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK
and £100.00 overseas per annum.
Views expressed by the contributors
do not necessarily represent those of
the publisher, editor or staff.
Material may not be reproduced in any form
without the publisher’s written permission.
© Copyright 2025 PharmaTimes Magazine.
All rights reserved. PharmaTimes Magazine
is published by PharmaTimes Media Ltd,
which is registered as a limited company
in England; No 09019637.